STOCK TITAN

Nephros First Quarter 2022 Financial Results Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) will release its first-quarter financial results on May 4, 2022, after market close. A conference call for investors is scheduled for the same day at 4:30 PM ET, with access numbers provided for domestic and international participants. An audio archive of the call will be available shortly after its conclusion. Nephros focuses on water filtration and pathogen detection solutions for healthcare and commercial sectors, promoting water safety through innovative technology.

Positive
  • Scheduled release of first-quarter financial results could provide insights into company performance.
  • Conference call allows direct communication with management for investors.
Negative
  • None.

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

A replay of the call can be accessed until May 11th, 2022 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access code: 3792199. 

An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

About Nephros

Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. For more information about Nephros, please visit us at nephros.com.

Investor RelationsContacts:

Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Andy Astor, CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com


FAQ

When will Nephros release its first-quarter financial results?

Nephros will release its first-quarter financial results on May 4, 2022, after market close.

What time is the Nephros conference call scheduled for?

The Nephros conference call is scheduled for May 4, 2022, at 4:30 PM ET.

How can I access the Nephros conference call?

Participants can dial 1 (844) 808-7106 for domestic access and 1 (412) 317-5285 for international access.

Is there a replay available for the Nephros conference call?

Yes, a replay of the call will be available until May 11, 2022, using the access code 3792199.

What is the focus of Nephros, Inc.?

Nephros, Inc. specializes in water filtration and pathogen detection solutions for medical and commercial markets.

Nephros Inc.

NASDAQ:NEPH

NEPH Rankings

NEPH Latest News

NEPH Stock Data

16.44M
9.24M
12.75%
40.93%
0.01%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SOUTH ORANGE